Immunological Features of AECHB

[1]  C. Grant,et al.  Liver immunology: How to reconcile tolerance with autoimmunity. , 2017, Clinics and research in hepatology and gastroenterology.

[2]  R. D. de Knegt,et al.  Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF). , 2016, Antiviral research.

[3]  Hong Tang,et al.  Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion. , 2016, Viral immunology.

[4]  B. Gao.  Basic liver immunology , 2016, Cellular & Molecular Immunology.

[5]  M. Gershwin,et al.  Adaptive immunity in the liver , 2016, Cellular & Molecular Immunology.

[6]  Vipin Kumar,et al.  NKT cell subsets as key participants in liver physiology and pathology , 2015, Cellular and Molecular Immunology.

[7]  Frank Tacke,et al.  Immunology in the liver — from homeostasis to disease , 2016, Nature Reviews Gastroenterology &Hepatology.

[8]  Jun-ying Zhou,et al.  The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation , 2016, Journal of medical virology.

[9]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[10]  E. Wisse,et al.  Liver natural killer cells: subsets and roles in liver immunity , 2015, Cellular and Molecular Immunology.

[11]  J. Hou,et al.  [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update]. , 2015, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[12]  M. Kumar,et al.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update , 2015, Hepatology International.

[13]  J. McCluskey,et al.  The burgeoning family of unconventional T cells , 2015, Nature Immunology.

[14]  Hong-Yan Liu,et al.  Innate immune recognition of hepatitis B virus. , 2015, World journal of hepatology.

[15]  R. Sun,et al.  Kupffer Cells Support Hepatitis B Virus–Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen–TLR2 Interactions in Mice , 2015, The Journal of Immunology.

[16]  Q. Ning,et al.  Upregulation of NKG2C+ Natural Killer Cells, TLR-2 Expression on Monocytes and Downregulation of Regulatory T-Cells Influence PEG-IFN Treatment Efficacy in Entecavir-Suppressed Patients with CHB , 2015, Antiviral therapy.

[17]  Dian-xing Sun,et al.  Interleukin-21 Inhibits HBV Replication in vitro , 2015, Antiviral therapy.

[18]  O. Fardel,et al.  Interleukin 6 inhibits HBV entry through NTCP down regulation. , 2015, Virology.

[19]  F. Hucke,et al.  Transarterial chemoembolization: modalities, indication, and patient selection. , 2015, Journal of hepatology.

[20]  Y. Gong,et al.  Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection , 2015, Digestive Diseases and Sciences.

[21]  Pei-Jer Chen,et al.  Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model , 2015, Cellular and Molecular Immunology.

[22]  Rony Thomas,et al.  Recent advances in management of acute liver failure , 2015, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[23]  Q. Xie,et al.  IL‐35: A potential therapeutic target for controlling hepatitis B virus infection , 2015, Journal of digestive diseases.

[24]  C. Ferrari.  HBV and the immune response , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[25]  G. Gerken,et al.  Toll‐like receptor‐mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen , 2014, Journal of viral hepatitis.

[26]  Zhiyong Ma,et al.  Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses , 2014, Cellular and Molecular Immunology.

[27]  J. Hou,et al.  Role of interleukin-21 in HBV infection: friend or foe? , 2014, Cellular and Molecular Immunology.

[28]  R. Chien,et al.  Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy. , 2014, Antiviral research.

[29]  Z. Tian,et al.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma , 2014, Cellular and Molecular Immunology.

[30]  Ding‐Shinn Chen,et al.  Reduced Toll-Like Receptor 9 Expression on Peripheral C D14+ Monocytes of Chronic Hepatitis B Patients and its Restoration by Effective Therapy , 2014, Antiviral therapy.

[31]  Praveen Kanneganti,et al.  Management of thrombocytopenia in advanced liver disease. , 2014, Canadian journal of gastroenterology & hepatology.

[32]  Meng-ji Lu,et al.  Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. , 2014, World journal of gastroenterology.

[33]  Yiyin Wang,et al.  Cellular immune response in patients with chronic hepatitis B virus infection. , 2014, Microbial pathogenesis.

[34]  R. Sun,et al.  γδT Cells Drive Myeloid-Derived Suppressor Cell–Mediated CD8+ T Cell Exhaustion in Hepatitis B Virus–Induced Immunotolerance , 2014, The Journal of Immunology.

[35]  Xiumin Ma,et al.  Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection. , 2014, International journal of clinical and experimental pathology.

[36]  H. Young,et al.  Interferons: Success in anti-viral immunotherapy. , 2014, Cytokine & growth factor reviews.

[37]  P. Ye,et al.  A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment. , 2014, Immunology letters.

[38]  S. Kent,et al.  Downregulation of Interleukin-18-Mediated Cell Signaling and Interferon Gamma Expression by the Hepatitis B Virus e Antigen , 2014, Journal of Virology.

[39]  J. Wendon,et al.  Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[40]  T. Liang,et al.  Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.

[41]  A. Busca,et al.  Innate immune responses in hepatitis B virus (HBV) infection , 2014, Virology Journal.

[42]  Zhan-lian Huang,et al.  High level of IL‐27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[43]  C. Chu,et al.  Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients , 2013, Hepatology.

[44]  D. J. Kim,et al.  Acute-on-chronic liver failure , 2013, Clinical and molecular hepatology.

[45]  Q. Ning,et al.  Combined Adenovirus-Mediated Artificial microRNAs Targeting mfgl2, mFas, and mTNFR1 Protect against Fulminant Hepatic Failure in Mice , 2013, PloS one.

[46]  Ding‐Shinn Chen,et al.  Reduced Toll-Like Receptor 3 Expression in Chronic Hepatitis B Patients and Its Restoration by Interferon Therapy , 2013, Antiviral therapy.

[47]  Y.-J. Ma,et al.  A Clinical Study of HBsAg‐Activated Dendritic Cells and Cytokine‐Induced Killer Cells During the Treatment for Chronic Hepatitis B , 2013, Scandinavian journal of immunology.

[48]  Xuan Huang,et al.  Circulating chemokine (C‐X‐C Motif) receptor 5+CD4+ T cells benefit hepatitis B e antigen seroconversion through IL‐21 in patients with chronic hepatitis B virus infection , 2013, Hepatology.

[49]  P. Kubes,et al.  Immune surveillance by the liver , 2013, Nature Immunology.

[50]  Z. Tian,et al.  Reversal of hepatitis B virus‐induced systemic immune tolerance by intrinsic innate immune stimulation , 2013, Journal of gastroenterology and hepatology.

[51]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[52]  R. Lanford,et al.  GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. , 2013, Gastroenterology.

[53]  Hai Li,et al.  Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV‐related acute‐on‐chronic liver failure , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[54]  C. Brander,et al.  Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. , 2013, Journal of hepatology.

[55]  Zhenghong Yuan,et al.  New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection , 2013, Antiviral therapy.

[56]  C. Trautwein,et al.  TRAIL but not FasL and TNFα, regulates IL‐33 expression in murine hepatocytes during acute hepatitis , 2012, Hepatology.

[57]  C. Aspord,et al.  Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. , 2012, Gastroenterology.

[58]  Y.‐C. Fan,et al.  Increased peripheral RORα and RORγt mRNA expression is associated with acute‐on‐chronic hepatitis B liver failure , 2012, Journal of viral hepatitis.

[59]  P. Lampertico,et al.  IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection , 2012, The Journal of Immunology.

[60]  P. Lampertico,et al.  Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. , 2012, Gastroenterology.

[61]  D. Arnett,et al.  Correction: A Powerful Test of Parent-of-Origin Effects for Quantitative Traits Using Haplotypes , 2012, PLoS ONE.

[62]  P. Lampertico,et al.  Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis. , 2012, Journal of hepatology.

[63]  Ding‐Shinn Chen,et al.  Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B , 2012, Hepatology International.

[64]  M. Dandri,et al.  New insight in the pathobiology of hepatitis B virus infection , 2012, Gut.

[65]  P. Hu,et al.  Enhanced Peripheral γδT Cells Cytotoxicity Potential in Patients with HBV-Associated Acute-On-Chronic Liver Failure Might Contribute to the Disease Progression , 2012, Journal of Clinical Immunology.

[66]  William M. Lee,et al.  Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011 , 2012, Hepatology.

[67]  Percy A. Knolle,et al.  Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.

[68]  Jiyuan Zhang,et al.  Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection , 2012, Journal of gastroenterology and hepatology.

[69]  M. Levrero,et al.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.

[70]  A. Bertoletti,et al.  Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.

[71]  A. Bertoletti,et al.  Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Gut.

[72]  M. Cobleigh,et al.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. , 2011, Gastroenterology.

[73]  S. Locarnini,et al.  The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. , 2011, Journal of hepatology.

[74]  H. Kuo,et al.  Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation. , 2011, Human immunology.

[75]  Shumei Lin,et al.  The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease , 2011, BMC Immunology.

[76]  Yong Yu,et al.  The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. , 2011, Viral immunology.

[77]  U. Protzer,et al.  Immune Control of Hepatitis B Virus , 2011, Digestive Diseases.

[78]  A. Kahraman,et al.  Role of stress‐induced NKG2D ligands in liver diseases , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[79]  Yanfang Jiang,et al.  High Frequency of CD4+CXCR5+ TFH Cells in Patients with Immune-Active Chronic Hepatitis B , 2011, PloS one.

[80]  J. Hou,et al.  Interleukin‐21 is upregulated in hepatitis B‐related acute‐on‐chronic liver failure and associated with severity of liver disease , 2011, Journal of viral hepatitis.

[81]  Lanjuan Li,et al.  Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. , 2011, Antiviral research.

[82]  M. Willart,et al.  Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. , 2011, American journal of respiratory and critical care medicine.

[83]  P. Kamath,et al.  Acute-on-chronic liver failure: concept, natural history, and prognosis , 2011, Current opinion in critical care.

[84]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[85]  H. Janssen,et al.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. , 2011, Journal of hepatology.

[86]  H. Janssen,et al.  Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function , 2011, PloS one.

[87]  Jiyuan Zhang,et al.  Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients , 2011, Hepatology.

[88]  M. Maini,et al.  Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection , 2010, PLoS pathogens.

[89]  Jiyuan Zhang,et al.  Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment , 2010, PloS one.

[90]  P. Tien,et al.  Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. , 2010, Biochemical and biophysical research communications.

[91]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[92]  F. Chisari,et al.  Pathogenesis of hepatitis B virus infection. , 2010, Pathologie-biologie.

[93]  A. Burroughs,et al.  Hemostasis and thrombosis in patients with liver disease: the ups and downs. , 2010, Journal of hepatology.

[94]  G. Auzinger,et al.  Acute liver failure , 2010, The Lancet.

[95]  Q. Ning,et al.  Acute liver failure: mechanisms of immune‐mediated liver injury , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[96]  M. Bonneville,et al.  γδ T cell effector functions: a blend of innate programming and acquired plasticity , 2010, Nature Reviews Immunology.

[97]  Q. Ning,et al.  Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. , 2010, Human gene therapy.

[98]  M. Maini,et al.  Innate and Adaptive Immune Responses in Hepatitis B Virus Infection , 2010, Digestive Diseases.

[99]  M. Hussain,et al.  Admission levels and early changes in serum interleukin‐10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[100]  R. Simon,et al.  B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failure , 2010, Proceedings of the National Academy of Sciences.

[101]  M. Lelonek,et al.  Two polymorphisms of the FVII gene and their impact on the risk of myocardial infarction in poles under 45 years of age , 2010, Molecular Biology.

[102]  Haiyang Xie,et al.  Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B , 2010, Journal of Clinical Immunology.

[103]  W. Born,et al.  Analysis of γδ T Cell Functions in the Mouse , 2010, The Journal of Immunology.

[104]  Zhi Chen,et al.  Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients , 2010, Journal of gastroenterology and hepatology.

[105]  Antonio Bertoletti,et al.  A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. , 2010, Journal of hepatology.

[106]  Jiyuan Zhang,et al.  Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B , 2010, Hepatology.

[107]  Ning Li,et al.  Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. , 2009, Biochemical and biophysical research communications.

[108]  Roger Williams,et al.  CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions , 2009, The Journal of Immunology.

[109]  Q. Ning,et al.  Increased Killing of Liver NK Cells by Fas/Fas Ligand and NKG2D/NKG2D Ligand Contributes to Hepatocyte Necrosis in Virus-Induced Liver Failure , 2009, The Journal of Immunology.

[110]  Hildegard Büning,et al.  Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.

[111]  A. Marshall,et al.  Phosphoinositide 3‐kinase‐regulated adapters in lymphocyte activation , 2009, Immunological reviews.

[112]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[113]  Zheng Zhang,et al.  Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus , 2009, Expert review of gastroenterology & hepatology.

[114]  M. Levrero,et al.  Control of cccDNA function in hepatitis B virus infection. , 2009, Journal of hepatology.

[115]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[116]  Zhan-qing Zhang,et al.  HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. , 2009, Molecular immunology.

[117]  S. Dooley,et al.  The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin‐13 as driving forces in fibrogenesis , 2009, Hepatology.

[118]  C. Benoist,et al.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes , 2009, Nature Immunology.

[119]  A. Bisceglie.  Hepatitis B and hepatocellular carcinoma , 2009 .

[120]  T. Liang.  Hepatitis B: The virus and disease , 2009, Hepatology.

[121]  A. D. Di Bisceglie.  Hepatitis B and hepatocellular carcinoma , 2009, Hepatology.

[122]  Dongliang Yang,et al.  Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells , 2009, Hepatology.

[123]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[124]  G. Koretzky,et al.  T cell activation. , 2009, Annual review of immunology.

[125]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[126]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 , 2009, Hepatology International.

[127]  C. Chu,et al.  Hepatitis B virus infection , 2009, The Lancet.

[128]  M. Massari,et al.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection , 2009, Gut.

[129]  R. Stravitz,et al.  Coagulopathy of acute liver failure. , 2009, Clinics in liver disease.

[130]  A. Osterhaus,et al.  In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens , 2009, Journal of medical virology.

[131]  Ying Sun,et al.  Imbalanced Intrahepatic Cytokine Expression of Interferon-γ, Tumor Necrosis Factor-α, and Interleukin-10 in Patients With Acute-on-Chronic Liver Failure Associated With Hepatitis B Virus Infection , 2009, Journal of clinical gastroenterology.

[132]  R. Binda,et al.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus , 2009, Immunology.

[133]  R. McCallum,et al.  Variation between centers in technique and guidelines for liver biopsy. , 2008, Liver.

[134]  P. Hu,et al.  Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection. , 2008, The Journal of infectious diseases.

[135]  Wei Guo,et al.  Hepatitis B Virus-induced hFGL2 Transcription Is Dependent on c-Ets-2 and MAPK Signal Pathway* , 2008, Journal of Biological Chemistry.

[136]  R. Stravitz.  Critical management decisions in patients with acute liver failure. , 2008, Chest.

[137]  Jinhong Chang,et al.  Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived Cells , 2008, Journal of Virology.

[138]  H. Niessner,et al.  Coagulation Abnormalities in Liver Disease , 2008, Seminars in thrombosis and hemostasis.

[139]  Zheng Zhang,et al.  Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. , 2008, Journal of hepatology.

[140]  S. Chokshi,et al.  Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e‐antigen seroconversion , 2008, Hepatology.

[141]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[142]  R. Casetti,et al.  The Plasticity of γδ T Cells: Innate Immunity, Antigen Presentation and New Immunotherapy , 2008, Cellular and Molecular Immunology.

[143]  K. Kärre.  Natural killer cell recognition of missing self , 2008, Nature Immunology.

[144]  G. Auzinger,et al.  Intensive care management of acute liver failure , 2008, Current opinion in critical care.

[145]  William M. Lee,et al.  The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring , 2008, Neurocritical care.

[146]  Zhi Chen,et al.  PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. , 2008, Molecular immunology.

[147]  G. Lau,et al.  Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. , 2007, Vaccine.

[148]  G. Gerken,et al.  Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice , 2007, Hepatology.

[149]  S. Urban,et al.  Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection , 2007, Clinical and experimental immunology.

[150]  A. Neumann,et al.  Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity , 2007, Antimicrobial Agents and Chemotherapy.

[151]  Andreas H Kramer,et al.  Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group , 2007, Critical care medicine.

[152]  R. Binda,et al.  Induction of Regulatory T-Cells and Interleukin-10-Producing Cells in Non-Responders to Pegylated Interferon-α Therapy for Chronic Hepatitis B , 2007, Antiviral therapy.

[153]  R. Sun,et al.  Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D‐ligand interaction and natural killer cells , 2007, Hepatology.

[154]  P. Tangkijvanich,et al.  Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. , 2007, Tissue antigens.

[155]  F. Leebeek,et al.  Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment , 2007, Digestive Surgery.

[156]  J. Ansell.  Factor Xa or thrombin: is factor Xa a better target? , 2007, Journal of thrombosis and haemostasis : JTH.

[157]  R. Schneider,et al.  Tumor Necrosis Factor Activates a Conserved Innate Antiviral Response to Hepatitis B Virus That Destabilizes Nucleocapsids and Reduces Nuclear Viral DNA , 2007, Journal of Virology.

[158]  E. Kuipers,et al.  Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. , 2007, Virology.

[159]  K. Wang,et al.  Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection , 2007, Journal of viral hepatitis.

[160]  P. Borrow,et al.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage , 2007, The Journal of experimental medicine.

[161]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[162]  Dougald M Monroe,et al.  Coagulation 2006: a modern view of hemostasis. , 2007, Hematology/oncology clinics of North America.

[163]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[164]  J. Backer,et al.  Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. , 2006, Molecular cell.

[165]  Boping Zhou,et al.  Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. , 2006, International immunology.

[166]  J. G. Kusters,et al.  Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV , 2006, Hepatology.

[167]  Y. Kondo,et al.  Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. , 2006, World journal of gastroenterology.

[168]  P. D. de Groot,et al.  Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.

[169]  Z. Zou,et al.  Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B1 , 2006, The Journal of Immunology.

[170]  Q. Ning,et al.  Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. , 2006, Human gene therapy.

[171]  R. C. Rodríguez de la Vega,et al.  K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. , 2006, Current pharmaceutical design.

[172]  A. Untergasser,et al.  Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection , 2006, Hepatology.

[173]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[174]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[175]  B. Rehermann,et al.  The liver as an immunological organ , 2006, Hepatology.

[176]  P. Bass,et al.  Tissue factor pathway inhibitor: structure, biology and involvement in disease , 2006, The Journal of pathology.

[177]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[178]  M. Braun,et al.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. , 2006, JAMA.

[179]  C. Gardiner,et al.  Putting the natural killer cell in its place , 2006, Immunology.

[180]  Ralf Bartenschlager,et al.  E2 of Hepatitis C Virus Inhibits Apoptosis1 , 2005, The Journal of Immunology.

[181]  Q. Ning,et al.  Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B. , 2005, World journal of gastroenterology.

[182]  Roger Williams,et al.  Lamivudine plus interleukin‐12 combination therapy in chronic hepatitis B: Antiviral and immunological activity , 2005, Hepatology.

[183]  M. Nesheim,et al.  HISTORICAL SKETCH: The discovery of TAFI , 2005, Journal of thrombosis and haemostasis : JTH.

[184]  P. Debré,et al.  FAS promoter polymorphisms correlate with activity grade in hepatitis C patients , 2005, European journal of gastroenterology & hepatology.

[185]  J. Kujovich.  Hemostatic defects in end stage liver disease. , 2005, Critical care clinics.

[186]  K. Hajjar,et al.  Molecular mechanisms of fibrinolysis , 2005, British journal of haematology.

[187]  F. Lammert,et al.  Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[188]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[189]  Pingan Zhang,et al.  Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. , 2005, World journal of gastroenterology.

[190]  P. Mannucci,et al.  Risk factors for thrombophilia in extrahepatic portal vein obstruction , 2005, Hepatology.

[191]  M. Shearer,et al.  Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. , 2005, Journal of hepatology.

[192]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[193]  J. O'grady,et al.  Acute liver failure , 2005, Postgraduate Medical Journal.

[194]  R. Offringa,et al.  SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. , 2005, Blood.

[195]  M. Manns,et al.  NFκB‐mediated upregulation of bcl‐xl restrains TRAIL‐mediated apoptosis in murine viral hepatitis , 2005, Hepatology.

[196]  H. Zhuang,et al.  Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2) , 2005, Journal of gastroenterology and hepatology.

[197]  M. Abougergi,et al.  Fas and TNFR1, but not cytolytic granule‐dependent mechanisms, mediate clearance of murine liver adenoviral infection , 2005, Hepatology.

[198]  J. Kinet,et al.  TRPM4 Regulates Calcium Oscillations After T Cell Activation , 2004, Science.

[199]  H. Zhuang,et al.  Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pDC) in Hepatitis B Virus Infected Humans , 2004, Journal of Clinical Immunology.

[200]  D. Adams,et al.  The composition of intrahepatic lymphocytes: shaped by selective recruitment? , 2004, Trends in immunology.

[201]  L. Chess,et al.  An integrated view of suppressor T cell subsets in immunoregulation. , 2004, The Journal of clinical investigation.

[202]  D. Farber,et al.  Signaling control of memory T cell generation and function. , 2004, Seminars in immunology.

[203]  G. McCaughan,et al.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.

[204]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[205]  J. Duguid,et al.  Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant , 2004, British journal of haematology.

[206]  C. Piccirillo,et al.  Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. , 2004, Trends in immunology.

[207]  R. Saxena,et al.  Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. , 2004, American journal of clinical pathology.

[208]  E. Wherry,et al.  Memory CD8 T-Cell Differentiation during Viral Infection , 2004, Journal of Virology.

[209]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[210]  J. Trapani,et al.  Granzyme M Mediates a Novel Form of Perforin-dependent Cell Death* , 2004, Journal of Biological Chemistry.

[211]  M. Abougergi,et al.  Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 61 , 2004, The Journal of Immunology.

[212]  T. Asahara,et al.  Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice , 2004, Hepatology.

[213]  Y. Baruch,et al.  Von Willebrand gene expression in damaged human liver. , 2004, Hepato-gastroenterology.

[214]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[215]  S. Lemon,et al.  Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. , 2004, Gastroenterology.

[216]  M. Duchen,et al.  The large-conductance Ca2+-activated K+ channel is essential for innate immunity , 2004, Nature.

[217]  Lieping Chen,et al.  T lymphocyte co-signaling pathways of the B7-CD28 family. , 2004, Cellular & molecular immunology.

[218]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[219]  J. V. van Mourik,et al.  Factor VIII expression in liver disease , 2003, Thrombosis and Haemostasis.

[220]  D. Mosher,et al.  Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[221]  T. Ley,et al.  Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.

[222]  W. Jefferies,et al.  Identification and Functional Characterization of Voltage-dependent Calcium Channels in T Lymphocytes* , 2003, Journal of Biological Chemistry.

[223]  Charles M. Rice,et al.  HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.

[224]  A. Bertoletti,et al.  Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. , 2003, Journal of hepatology.

[225]  C. Esmon.  The protein C pathway. , 2003, Critical care medicine.

[226]  Y. S. Hahn,et al.  Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? , 2003, Current opinion in immunology.

[227]  Q. Ning,et al.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. , 2003, The Journal of clinical investigation.

[228]  R. Kerr,et al.  New insights into haemostasis in liver failure , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[229]  Y. Ikeda,et al.  A role of autoantibody‐mediated platelet destruction in thrombocytopenia in patients with cirrhosis , 2003, Hepatology.

[230]  Q. Ning,et al.  Induction of Prothrombinase fgl2 by the Nucleocapsid Protein of Virulent Mouse Hepatitis Virus Is Dependent on Host Hepatic Nuclear Factor-4α* , 2003, The Journal of Biological Chemistry.

[231]  S. Korsmeyer,et al.  Cell death induced by granzyme C. , 2003, Blood.

[232]  M. Boffa,et al.  Acute Phase Mediators Modulate Thrombin-activable Fibrinolysis Inhibitor (TAFI) Gene Expression in HepG2 Cells* , 2003, The Journal of Biological Chemistry.

[233]  Y. Liaw.  Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti‐hepatitis B virus therapy 1 , 2003, Journal of gastroenterology and hepatology.

[234]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[235]  H. Maniar,et al.  Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses , 2002, Immunological reviews.

[236]  E. Seifried,et al.  Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. , 2002, Thrombosis research.

[237]  F. Braet,et al.  Hepatic Natural Killer Cells Exclusively Kill Splenic/blood Natural Killer-resistant Tumor Cells by the Perforin/granzyme Pathway , 2022 .

[238]  C. Wai,et al.  Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B , 2002, Gut.

[239]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[240]  D. K. Kuharsky,et al.  Relief of Extrinsic Pathway Inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated Hepatocyte Apoptosis* , 2002, The Journal of Biological Chemistry.

[241]  G. Papatheodoridis,et al.  Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. , 2002 .

[242]  D. Curiel,et al.  Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver , 2002, Journal of Virology.

[243]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[244]  P. Marsden,et al.  Kinetic Analysis of a Unique Direct Prothrombinase, fgl2, and Identification of a Serine Residue Critical for the Prothrombinase Activity1 , 2002, The Journal of Immunology.

[245]  F. Chisari,et al.  Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice , 2002, Journal of Virology.

[246]  A. Thomson,et al.  Immunobiology of liver dendritic cells , 2002, Immunology and cell biology.

[247]  B. Schraven,et al.  Adapters in lymphocyte signaling. , 2002, The Journal of clinical investigation.

[248]  C. Tseng,et al.  Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.

[249]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[250]  F. Chisari,et al.  Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.

[251]  J. Lieberman,et al.  Granzyme A Activates an Endoplasmic Reticulum-associated Caspase-independent Nuclease to Induce Single-stranded DNA Nicks* , 2001, The Journal of Biological Chemistry.

[252]  G. Gores,et al.  The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis* , 2001, The Journal of Biological Chemistry.

[253]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[254]  J. Morrissey,et al.  Tissue Factor: An Enzyme Cofactor and a True Receptor , 2001, Thrombosis and Haemostasis.

[255]  H. Vilstrup,et al.  Recombinant Activated Factor VII (rFVIIa) Acutely Normalizes Prothrombin Time in Patients with Cirrhosis During Bleeding from Oesophageal Varices , 2001, Scandinavian journal of gastroenterology.

[256]  R. de Waal Malefyt,et al.  IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.

[257]  M. Houghton,et al.  Characterization of liver T‐cell receptor γδ+ T cells obtained from individuals chronically infected with hepatitis C virus (HCV): Evidence for these T cells playing a role in the liver pathology associated with HCV infections , 2001, Hepatology.

[258]  M. Shima,et al.  Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein* , 2001, The Journal of Biological Chemistry.

[259]  C. W. Chan,et al.  Fulminant viral hepatitis: molecular and cellular basis, and clinical implications , 2001, Expert Reviews in Molecular Medicine.

[260]  P. Cahill,et al.  Endothelial dysfunction in cirrhosis and portal hypertension. , 2001, Pharmacology & therapeutics.

[261]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[262]  P. Marsden,et al.  Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. , 2001, Genomics.

[263]  V. Giedraitis,et al.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation , 2001, Journal of Neuroimmunology.

[264]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[265]  F. Chisari,et al.  Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.

[266]  H. Moriwaki,et al.  High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. , 2000, The Journal of infectious diseases.

[267]  R. D. de Man,et al.  Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. , 2000, Journal of hepatology.

[268]  R. D. de Man,et al.  Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy , 2000, Hepatology.

[269]  Li Zhang,et al.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression , 2000, Nature Medicine.

[270]  Mannucci.  Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[271]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[272]  C. Disteche,et al.  A Novel B Lymphocyte–Associated Adaptor Protein, Bam32, Regulates Antigen Receptor Signaling Downstream of Phosphatidylinositol 3-Kinase , 2000, The Journal of experimental medicine.

[273]  T. Reynolds,et al.  Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit , 2000, American Journal of Gastroenterology.

[274]  D. Doherty,et al.  Innate and adaptive lymphoid cells in the human liver , 2000, Immunological reviews.

[275]  P. Marsden,et al.  Molecular and Functional Analysis of the Human Prothrombinase Gene (HFGL2) and Its Role in Viral Hepatitis , 2000, The American Journal of Pathology.

[276]  K. Takeda,et al.  The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses , 2000, Immunological reviews.

[277]  J. Powers,et al.  Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. , 2000, Biochimica et biophysica acta.

[278]  V. Kaul,et al.  Coagulopathy of liver disease , 2000, Current treatment options in gastroenterology.

[279]  C. Brosnan,et al.  Evidence for γδ T cells with a restricted Vδ6 junctional region in the normal mouse central nervous system , 1999, Journal of Neuroimmunology.

[280]  H. Takada,et al.  Escherichia coli infection induces only fetal thymus‐derived γ δ T cells at the infected site , 1999 .

[281]  J. Moffett,et al.  Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells. , 1999, Human gene therapy.

[282]  A. Burroughs,et al.  Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? , 1999, American Journal of Gastroenterology.

[283]  A. Grant,et al.  Guidelines on the use of liver biopsy in clinical practice , 1999, Gut.

[284]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[285]  T. Kato,et al.  Liver cirrhosis with marked thrombocytopenia and highly elevated serum thrombopoietin levels. , 1999, International journal of hematology.

[286]  Kyong‐Mi Chang.  Immunopathogenesis of hepatitis C virus infection. , 1999, Clinics in liver disease.

[287]  A. Burroughs,et al.  Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation , 1999, Gut.

[288]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[289]  M. Lai,et al.  The Nucleocapsid Protein of Murine Hepatitis Virus Type 3 Induces Transcription of the Novel fgl2 Prothrombinase Gene* , 1999, The Journal of Biological Chemistry.

[290]  M. Hohenegger,et al.  Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose , 1999, Nature.

[291]  P. Bird.  Regulation of pro‐apoptotic leucocyte granule serine proteinases by intracellular serpins , 1999, Immunology and cell biology.

[292]  J. Wilson,et al.  Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer. , 1999, Human gene therapy.

[293]  M. Boffa,et al.  A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor* , 1998, The Journal of Biological Chemistry.

[294]  Q. Ning,et al.  Fulminant Hepatic Failure in Murine Hepatitis Virus Strain 3 Infection: Tissue-Specific Expression of a Novel fgl2 Prothrombinase , 1997, Journal of Virology.

[295]  Q. Ning,et al.  Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase , 1997 .

[296]  J. Tschopp,et al.  In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells , 1997, The Journal of experimental medicine.

[297]  R. Williams,et al.  Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. , 1997, The Journal of clinical investigation.

[298]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[299]  P. Mannucci,et al.  High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia , 1996, Hepatology.

[300]  F. Chisari,et al.  Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. , 1996, The Journal of clinical investigation.

[301]  F. Chisari,et al.  High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.

[302]  D. Malo,et al.  Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5. , 1995, Genomics.

[303]  J. Leibowitz,et al.  Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity , 1995, Journal of virology.

[304]  M. Shearer.  Vitamin K , 1995, The Lancet.

[305]  R. Treisman,et al.  The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.

[306]  J. Loscalzo,et al.  Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences. , 1994, Blood.

[307]  R. Hughes,et al.  Activation of the fibrinolytic system in patients with fulminant liver failure , 1993, Hepatology.

[308]  P. Mannucci,et al.  Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: A multicenter, double‐blind study , 1993 .

[309]  P. Mannucci,et al.  Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club. , 1993, Hepatology.

[310]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[311]  E. Cecchi,et al.  Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. , 1993, Gastroenterology.

[312]  P. Romagnoli,et al.  Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. , 1992, Gastroenterology.

[313]  J. Wilson,et al.  Disseminated intravascular coagulation in liver cirrhosis. , 1992, Journal of hepatology.

[314]  T. Ishikawa,et al.  Serum interleukin 6 levels in patients with chronic hepatitis B. , 1991, The American journal of gastroenterology.

[315]  K. Matthes,et al.  Coagulation activation in liver diseases. , 1991, Thrombosis Research.

[316]  J. M. Carr.  Disseminated intravascular coagulation in cirrhosis , 1989, Hepatology.

[317]  P. Mistry,et al.  INHIBITION OF PLATELET AGGREGATION BY ABNORMAL HIGH DENSITY LIPOPROTEIN PARTICLES IN PLASMA FROM PATIENTS WITH HEPATIC CIRRHOSIS , 1989, The Lancet.

[318]  M. Ruggiero,et al.  Altered platelet function in cirrhosis of the liver: Impairment of inositol lipid and arachidonic acid metabolism in response to agonists , 1988, Hepatology.

[319]  R. Francis,et al.  The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor. , 1987, Blood.

[320]  S. Tonegawa,et al.  Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[321]  B. Furie,et al.  Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin. , 1986, The Journal of biological chemistry.

[322]  J. Spivak,et al.  Effect of ethanol on thrombopoiesis , 1986, British journal of haematology.

[323]  A. Gimson,et al.  Serological markers in fulminant hepatitis B. , 1983, Gut.

[324]  J. T. ten Cate,et al.  Antithrombin III transfusion in patients with hepatic cirrhosis , 1982, British journal of haematology.

[325]  P. Mannucci,et al.  DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATION , 1982, The Lancet.

[326]  J. Fischer,et al.  Disseminated intravascular coagulation with the peritoneovenous shunt. , 1979, Annals of internal medicine.

[327]  J. Motin,et al.  Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. , 1976, Gut.

[328]  V. Turitto,et al.  Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. , 1975, Microvascular research.

[329]  M. Himeno,et al.  Separation and Structure of Components of Nuclear Polyhedrosis Virus of the Silkworm , 1971, Journal of virology.

[330]  R. Aster.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.

[331]  Every Rg.  Persistence of treponemes after treatment of syphilis. , 1965, Lancet.

[332]  D. Doherty.  Immunity, tolerance and autoimmunity in the liver: A comprehensive review. , 2016, Journal of autoimmunity.

[333]  M. Heikenwalder,et al.  Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. , 2016, Gastroenterology.

[334]  H. Bitter,et al.  Reduction of HBV replication prolongs the early immunological response to IFNα therapy. , 2014, Journal of hepatology.

[335]  S. Bae,et al.  Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. , 2013, Clinical and experimental rheumatology.

[336]  Lai Wei,et al.  Frequency of T-cell FoxP3⁺ Treg and CD4⁺/CD8⁺ PD-1 expression is related to HBeAg seroconversion in hepatitis B patients on pegylated interferon. , 2013, Chinese medical journal.

[337]  13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure. , 2013, Hepatobiliary & pancreatic diseases international : HBPD INT.

[338]  Z. Tian,et al.  The role of innate immunity in HBV infection , 2012, Seminars in Immunopathology.

[339]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[340]  J. Niu,et al.  Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies , 2011, Cellular and Molecular Immunology.

[341]  S. Zeuzem,et al.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2011, Journal of hepatology.

[342]  Hong Zhao,et al.  Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B , 2010, Inflammation Research.

[343]  Lanjuan Li,et al.  Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection. , 2010, Cellular immunology.

[344]  J. Veselka,et al.  The role of tissue factor in thrombosis and hemostasis. , 2007, Physiological research.

[345]  H. Kuo,et al.  HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. , 2007, Journal of biomedical science.

[346]  J. Orange,et al.  Natural killer cells in human health and disease. , 2006, Clinical immunology.

[347]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[348]  E. Elinav,et al.  The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. , 2005, Journal of hepatology.

[349]  P. Ashton‐Rickardt.  The granule pathway of programmed cell death. , 2005, Critical reviews in immunology.

[350]  U. Hedner.  Dosing with recombinant factor viia based on current evidence. , 2004, Seminars in hematology.

[351]  YOUHAI H. Chen,et al.  Critical roles of TRAIL in hepatic cell death and hepatic inflammation. , 2004, The Journal of clinical investigation.

[352]  F. Sofi,et al.  Protein Z: "light and shade" of a new thrombotic factor. , 2004, Clinical laboratory.

[353]  K. Mann,et al.  Blood Coagulation , 2004, Biochemistry (Moscow).

[354]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[355]  M. Irwin,et al.  Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[356]  G. Papatheodoridis,et al.  Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance , 2002, American Journal of Gastroenterology.

[357]  G. Escolar,et al.  Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation. , 1999, Haematologica.

[358]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[359]  D. Doherty,et al.  Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. , 1998, Journal of hepatology.

[360]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[361]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[362]  D. Armstrong,et al.  Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease. , 1982, Haemostasis.